Patent ID: 9421233
Filing Date: 2016-08-23
CPC Classification: A61K,C12Q

Claim Text:
1. A method of diagnosing susceptibility to inflammatory bowel disease (IBD) in a subject, and treating said subject, comprising: obtaining a sample from the subject; subjecting the sample to a genotyping assay adapted to determine the presence or absence of one or more risk variants at the Dectin-1 gene (CLEC7A), wherein the genotyping assay comprises using quantitative polymerase chain reaction (qPCR), and wherein the one or more risk variants comprises rs2078178 (SEQ ID NO: 27), rs16910631 (SEQ ID NO: 28) or a combination thereof; diagnosing susceptibility to IBD in the subject based on the presence of one or more risk variants at the Dectin-1 gene (CLEC7A); and administering an anti-fungal drug to the subject.